Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance Therapy With Toripalimab Combined With Capecitabine Versus Maintenancetherapy With Capecitabine Alone in High-risk Nasopharyngeal Carcinoma: a Multicenter, Prospective, Randomized Phase III Clinical Trial (NPC-ICMB)

NCT06277050 is registered in ClinicalTrials.gov with Jiangxi Provincial Cancer Hospital as lead sponsor.

NCT NCT06277050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance Therapy With Toripalimab Combined With Capecitabine Versus Maintenancetherapy With Capecitabine Alone in High-risk Nasopharyngeal Carcinoma: a Multicenter, Prospective, Randomized Phase III Clinical Trial (NPC-ICMB)
Lead sponsor
Jiangxi Provincial Cancer Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
March 7, 2024
Completion date
February 20, 2031
Enrollment
264 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk cancer, maintenance therapy, nasopharyngeal carcinoma